Partner Relations
Founded in 2010, the ATA Corporate Leadership Council (CLC) provides a unique and valuable forum for open communication between the ATA and the community of corporations that share interest in thyroid health and biology.
The ATA has created and made available at its web site this complete Institutional Conflict of Interest Disclosure, which will be updated annually.
Corporate Leadership Council Members
Abbott India
www.abbott.co.in
Abbott India Limited (AIL) is one of India’s fastest growing pharmaceutical businesses. Headquartered in Mumbai, Abbott India Limited, is a publicly listed company (BSE: ABBOT) and a subsidiary of Abbott Laboratories, USA. The Company enjoys a leading presence in multiple therapeutic categories including Women’s Health, Gastroenterology, Neuro-psychiatry, Thyroid management and Liver health. Its success is driven by a combination of a highly competent and motivated team, R&D backed products, and strong alliances and partnerships with its suppliers and customers. Abbott India Limited reaches customers through a network of 25 distribution points which cater to over 5,200 stockists and 150,000 retail outlets. Visit us at: http://www.abbott.co.in
AbbVie
www.abbvie.com
AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.
Eisai, Inc.
www.eisai.com/US
100 Tice Boulevard
Woodcliff Lake, NJ 07677
As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., our passionate commitment to patient care is the driving force behind our efforts to help address unmet medical needs. We are a fully integrated pharmaceutical business with discovery, clinical, manufacturing and marketing capabilities. Our key areas of commercial focus include oncology and specialty care (Alzheimer’s disease, epilepsy and metabolic disorders). To learn more about Eisai Inc., please visit us at www.eisai.com/US
Exelixis, Inc.
www.exelixis.com
Exelixis is a biopharmaceutical company committed to developing and commercializing small molecule therapies for the treatment of cancer. We are committed to excellence in all aspects of our work and are dedicated to improving the care and outcome of cancer patients.
Genzyme Corporation
www.genzyme.com
500 Kendall Street
Cambridge, MA 02142
Phone: (617) 252-7500
Genzyme, a Sanofi company, has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years. With a focus on rare diseases and multiple sclerosis, we are dedicated to making a positive impact on the lives of the patients and families we serve. Visit www.genzyme.com.
Quest Diagnostics
Quest Diagnostics offers comprehensive, integrated and innovative Thyroid Cancer Testing Solutions to provide you with the diagnostic insights you need to effectively diagnose and treat your patients. With nearly 800 M.D. and Ph.D level professionals we are a leader in the medical laboratory industry. We provide a comprehensive diagnostic portfolio for Thyroid Cancer, from screening and diagnosis to prognosis, treatment selection and monitoring. Our consultative network for Thyroid Pathology is comprised of board-certified pathologists with extensive experience in Thyroid Cancer. Find out more at www.QuestDiagnostics.com
Mary Ann Liebert, Inc. Publishers
www.liebertpub.com
140 Huguenot Street, 3rd Floor
New Rochelle, NY 10801
Phone: (914) 740-2100
Mary Ann Liebert, Inc. publishes authoritative peer-reviewed journals in promising areas of science and biomedical research, including Thyroid, the Official Journal of the American Thyroid Association. Thyroid (www.liebertpub.com/thy), published in print and online monthly, is the leading, peer-reviewed resource for original articles, patient-focused reports, and translational research on thyroid cancer and all thyroid related diseases. The Journal delivers the latest findings on topics from primary care to clinical application, and is the exclusive source for the authoritative and updated ATA Guidelines for Managing Thyroid Disease.
Spectrix Therapeutics, LLC
www.Spectrixtx.com
1256 Main Street, Ste 249
Southlake, TX 76092
Spectrix Therapeutics, LLC is a privately-held specialty pharmaceutical company committed to transforming how metabolic and endocrine disorders are treated pharmacologically. Through application of our proprietary multi-particulate drug delivery technologies we are able to provide tailored drug profiles to achieve optimal therapeutic effect, thereby enriching patient quality of life and further fueling the progress of medicine.
Ethicon
4545 Creek Road
Cincinnati, OH 45242
From creating the first sutures, to revolutionizing surgery with minimally invasive procedures, Ethicon, part of the Johnson & Johnson Medical Devices Companies, has made significant contributions to surgery for more than 60 years. Our continuing dedication to Shape the Future of Surgery is built on our commitment to help address the world’s most pressing health care issues, and improve and save more lives. Through Ethicon’s surgical technologies and solutions including sutures, staplers, energy devices, trocars and hemostats and our commitment to treat serious medical conditions like obesity and cancer worldwide, we deliver innovation to make a life-changing impact. Learn more at www.ethicon.com, and follow us on Twitter @Ethicon.
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.